NEUROCARRUS
Neurocarrus is developing a new way to treat human pain. Using protein engineering, they created a novel, non-opioid therapeutic that targets sensory neurons to “freeze” pain signals before they ever get to the brain. Promising laboratory and animal model findings show that their therapeutic, N-001, lasts longer than opioids while providing equivalent pain relief. Their mission is to improve the quality of life for people suffering from chronic pain and at the same time, provide an urgently ... needed alternative to addictive opioids in the midst of the raging national epidemic. In addition, N-001’s unique drug delivery platform holds great promise for partnership with other therapies or identification needs related to sensory neurons. Neurocarrus has an exclusive license to both our drug and the delivery system for all fields of use.
NEUROCARRUS
Industry:
Biopharma Health Care Medical
Founded:
2015-12-04
Address:
Lincoln, Nebraska, United States
Country:
United States
Website Url:
http://www.neurocarrus.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
100 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Font Awesome
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Thermaquil
Thermaquil is developing the ideal reversible nerve block device to manage severe pain without drugs or electric stimulation.
Current Employees Featured
Founder
Investors List
Christoph Lymbersky
Christoph Lymbersky investment in Seed Round - Neurocarrus
SOSV
SOSV investment in Seed Round - Neurocarrus
IndieBio
IndieBio investment in Seed Round - Neurocarrus
Newest Events participated
Official Site Inspections
http://www.neurocarrus.com Semrush global rank: 3.28 M Semrush visits lastest month: 4.98 K
- Host name: 59.0.153.160.host.secureserver.net
- IP address: 160.153.0.59
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Neurocarrus"
Neurocarrus | Transforming the way we treat pain
Neurocarrus is a biotechnology company developing a novel drug delivery technology to safely disrupt pain signals without addiction-forming medications or disruption of muscular control. …See details»
Neurocarrus - Crunchbase Company Profile & Funding
Neurocarrus is developing a new way to treat human pain. Using protein engineering, they created a novel, non-opioid therapeutic that targets sensory neurons to “freeze” pain signals …See details»
Welcome Neurocarrus - Bio Nebraska
Neurocarrus is a biotech company developing a novel drug technology to safely disrupt pain signals without risk of addiction or other systemic effects.See details»
Welcome Neurocarrus - Bio Nebraska
Mar 3, 2021 · Neurocarrus is a university spinout founded by Paul Blum a co-inventor of the recently patented technology. The company has exclusively licensed the IP for all fields of use including the delivery of other therapeutics …See details»
Neurocarrus - LinkedIn
Neurocarrus is developing a novel therapy to treat pain without addiction. We are a biotechnology company developing a novel drug delivery technology to safely disrupt pain signals without...See details»
Neurocarrus Company Profile 2024: Valuation, Funding
Developer of a novel drug delivery technology designed to safely disrupt pain signals without addiction-forming medications or disruption of muscular control.See details»
Neurocarrus - VentureRadar
Neurocarrus is a biotechnology company developing a novel drug delivery technology to safely disrupt pain signals without addiction-forming medications or disruption of muscular control. …See details»
Treating Pain Without Opioids – Research at Nebraska
To help blunt the opioid crisis and help millions of pain sufferers, Nebraska biologist Paul Blum and his team created a drug that targets pain at its source, leaving the rest of the nervous system, including the brain, alone.See details»
Neurocarrus - Funding, Financials, Valuation & Investors
Neurocarrus is developing a novel drug and delivery technology to treat chronic pain without addiction or disruption of muscular control.See details»
Biopharma R&D Business Development Platform - Bioneex
Neurocarrus is a drug development biotech company headquartered in Lincoln, Nebraska. The company was founded by prominent research scientists in the field of protein engineering from …See details»
Paul Blum - CEO and Co-Founder @ Neurocarrus - Crunchbase
Paul Blum has 3 current jobs including Adjunct Professor at University of California, Santa Cruz, CEO and Co-Founder at Neurocarrus, and Professor at University of Nebraska.See details»
Neurocarrus Inc. | CipherBio
Explore Neurocarrus Inc.'s investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Paul Blum, Ph.D. - Neurocarrus
Co-Founder and CEO. Paul brings over 25 years of research experience and insight in protein engineering and microbiology, with an emphasis on multidomain proteins and enzymes.See details»
2024 | Neurocarrus
We’re excited to announce the launch of Neurocarrus’s equity crowdfunding campaign. We’re partnering with Wefunder, a platform for individual investors. Our campaign is live! Read more …See details»
Preclinical characterization of the efficacy and safety of biologic N ...
To assess the relevance of N‐001 for treatment of acute post‐surgical pain, the current study evaluated the eficacy of N‐001 in a mouse hind‐paw incision model by peri‐ incisional and …See details»
Neurocarrus - Contacts, Employees, Board Members, Advisors
Neurocarrus is developing a novel drug and delivery technology to treat chronic pain without addiction or disruption of muscular control.See details»
Neurocarrus: Treating Pain Without Addictive Opioids - IndieBio
Apr 14, 2018 · The Opioid Crisis is a reality we’re facing now—but what if pain could be treated another way? That’s exactly what Neurocarrus has been working on. Their new drug delivery …See details»
11 | Neurocarrus
We’re excited to announce the launch of Neurocarrus’s equity crowdfunding campaign. We’re partnering with Wefunder, a platform for individual investors. Our campaign is live! Read more …See details»
Neurocarrus - Alien Technology Transfer
Website: https://neurocarrus.com A pressing demand exists for innovative approaches to manage acute human pain while mitigating the risk of Substance Use Disorders (SUDs). Traditional …See details»
home_staff | Groups | Neurocarrus
Help us bring relief without addiction to people in pain. We’re excited to announce the launch ofSee details»